Back to News
Market Impact: 0.6

We're raising our price target on Goldman Sachs after a blowout quarter, upbeat outlook

AAPL
D
FCD.UN.TO
GOOGL
GS
GSBD
JPM
LMT
+5
Corporate EarningsCompany FundamentalsCapital Returns (Dividends / Buybacks)Analyst InsightsTechnology & InnovationAntitrust & CompetitionM&A & RestructuringBanking & Liquidity
We're raising our price target on Goldman Sachs after a blowout quarter, upbeat outlook

Goldman Sachs delivered a blowout Q2: revenue rose 39.5% YoY to $20.34B (vs. $16.13B consensus) and EPS jumped 92% to $20.98 (vs. $14.48 consensus), driving shares up 7.5% to fresh all-time highs near ~$1,136. Key efficiency improved with the efficiency ratio at 57.4% (multi-year low) and return on tangible common equity at 25.5%, while investment banking and trading revenues beat consensus across equities (+72% to $7.42B) and FICC (+32% to $4.6B). Management highlighted backlog rising to the highest level in five years and raised the price target to $1,200 from $1,050, though the article notes cyclicality risk tied to the AI/trading backdrop.

Analysis

This is less a one-quarter story than a signal that Goldman’s earnings power is becoming more convex to capital-markets reopenings than the market modeled. When underwriting, trading, and client activity all accelerate together, the bank’s operating leverage can outperform even in a high base-rate world, which argues for further estimate revisions across the bulge-bracket complex. The second-order winner is the rest of the fee pool: exchange, prime brokerage, and advisory-adjacent names should see better tone, while borrowers tied to AI capex benefit from a more reliable financing window.

The near-term risk is that volatility normalizes faster than deal flow converts, which would leave trading revenues vulnerable before M&A and IPO fees can fully replace them. Over the next 1-3 months, the key catalyst is backlog-to-revenue conversion; if the pipeline stalls, the stock can still de-rate even with a strong headline quarter. Over 6-18 months, the real debate is mix shift: if wealth/AWM keeps compounding, Goldman can sustain a higher multiple; if not, it remains a cyclical franchise whose premium must be justified every quarter.

The consensus may be missing that this can be a durable rerating catalyst only if the current policy/regulatory backdrop and AI funding cycle both persist; either one can fade quickly. I think the market is at risk of over-forecasting the permanence of this quarter’s trading windfall, but underestimating the compounding effect of recurring wealth revenues. That makes the best risk/reward to own GS on dips rather than chase, while using relative-value expressions to isolate the alpha from broader bank beta.